ES2059588T3 - Factor xiii para la prevencion de una hemorragia intraventricular. - Google Patents
Factor xiii para la prevencion de una hemorragia intraventricular.Info
- Publication number
- ES2059588T3 ES2059588T3 ES89102471T ES89102471T ES2059588T3 ES 2059588 T3 ES2059588 T3 ES 2059588T3 ES 89102471 T ES89102471 T ES 89102471T ES 89102471 T ES89102471 T ES 89102471T ES 2059588 T3 ES2059588 T3 ES 2059588T3
- Authority
- ES
- Spain
- Prior art keywords
- prevention
- factor xiii
- intraventricular hemorrhage
- intraventricular
- hemorrhage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
EL FACTOR XIII DE COAGULACION DE SANGRE HUMANA PERMITE LA PREVENCION DE HEMORRAGIA INTRAVENTICULAR CUANDO SE ADMINISTRA A BEBES PREMATUROS, PREFERENTEMENTE POR INYECCION INTRAVENOSA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63039646A JPH01216939A (ja) | 1988-02-24 | 1988-02-24 | 末熟児頭蓋内出血阻止剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2059588T3 true ES2059588T3 (es) | 1994-11-16 |
Family
ID=12558846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89102471T Expired - Lifetime ES2059588T3 (es) | 1988-02-24 | 1989-02-14 | Factor xiii para la prevencion de una hemorragia intraventricular. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5114916A (es) |
EP (1) | EP0330049B1 (es) |
JP (1) | JPH01216939A (es) |
KR (1) | KR0137476B1 (es) |
AT (1) | ATE94070T1 (es) |
AU (1) | AU613154B2 (es) |
CA (1) | CA1332352C (es) |
DE (1) | DE68908913T2 (es) |
DK (1) | DK174978B1 (es) |
ES (1) | ES2059588T3 (es) |
IE (1) | IE63656B1 (es) |
PT (1) | PT89802B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5612456A (en) * | 1988-11-14 | 1997-03-18 | Zymogenetics, Inc. | Factor XIII compositions |
ATE171071T1 (de) * | 1991-12-31 | 1998-10-15 | Zymogenetics Inc | Verfahren und zusammensetzungen zur verminderung von blutverlust |
DE69328228T2 (de) * | 1992-04-21 | 2000-12-21 | Ajinomoto Co., Inc. | Wundheilmittel |
ES2139729T3 (es) * | 1992-11-12 | 2000-02-16 | Zymogenetics Inc | Uso del factor xiii aplicado topicamente para la inhibicion de hemorragias. |
JPH07328108A (ja) * | 1994-06-10 | 1995-12-19 | Ajinomoto Co Inc | 生体組織接着剤及び血液凝固剤 |
CN1896231B (zh) | 1998-08-06 | 2012-09-05 | 山景药品公司 | 分离四聚体尿酸氧化酶的方法 |
EP1784415A2 (en) * | 2004-08-27 | 2007-05-16 | Novo Nordisk Health Care AG | Purification of factor xiii polypeptides from biological materials |
JP5086093B2 (ja) * | 2004-11-23 | 2012-11-28 | ジモジェネティクス、インコーポレイテッド | 組換え型ヒトxiii因子の精製 |
LT3321359T (lt) | 2005-04-11 | 2021-05-10 | Horizon Pharma Rheumatology Llc | Urato oksidazės variantinės formos ir jų panaudojimas |
TWI418564B (zh) * | 2005-04-11 | 2013-12-11 | Savient Pharmaceuticals Inc | 利用陽離子界面活性劑之蛋白質純化 |
EP2013225B1 (en) * | 2006-04-12 | 2014-12-17 | Crealta Pharmaceuticals LLC | Purification of proteins with cationic surfactant |
HUP1200205A3 (en) | 2009-06-25 | 2012-09-28 | Savient Pharmaceuticals | Method and kits for perdicting infusion reaction risk and antibody-mediated low of response by monitoring serum uric acid during pegylated uricare therapy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3717708A (en) * | 1968-10-24 | 1973-02-20 | Cutter Lab | Blood coagulation complex |
DE2063070C3 (de) * | 1970-12-22 | 1975-07-24 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung eines Arzneimittels mit fibrinstabilisierender Wirkung |
DE3622642A1 (de) * | 1986-07-05 | 1988-01-14 | Behringwerke Ag | Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung |
EP0268772B1 (en) * | 1986-09-19 | 1995-04-26 | ZymoGenetics, Inc. | Expression of biologically active factor XIII |
-
1988
- 1988-02-24 JP JP63039646A patent/JPH01216939A/ja active Granted
-
1989
- 1989-02-14 ES ES89102471T patent/ES2059588T3/es not_active Expired - Lifetime
- 1989-02-14 EP EP89102471A patent/EP0330049B1/en not_active Expired - Lifetime
- 1989-02-14 DE DE89102471T patent/DE68908913T2/de not_active Expired - Lifetime
- 1989-02-14 AT AT89102471T patent/ATE94070T1/de not_active IP Right Cessation
- 1989-02-23 KR KR1019890002127A patent/KR0137476B1/ko not_active IP Right Cessation
- 1989-02-23 PT PT89802A patent/PT89802B/pt not_active IP Right Cessation
- 1989-02-23 IE IE58089A patent/IE63656B1/en not_active IP Right Cessation
- 1989-02-23 AU AU30243/89A patent/AU613154B2/en not_active Expired
- 1989-02-23 CA CA000591929A patent/CA1332352C/en not_active Expired - Lifetime
- 1989-02-23 DK DK198900838A patent/DK174978B1/da not_active IP Right Cessation
-
1990
- 1990-02-14 US US07/480,358 patent/US5114916A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE68908913D1 (de) | 1993-10-14 |
KR0137476B1 (ko) | 1998-06-01 |
CA1332352C (en) | 1994-10-11 |
DK174978B1 (da) | 2004-04-05 |
JPH0378850B2 (es) | 1991-12-17 |
JPH01216939A (ja) | 1989-08-30 |
PT89802B (pt) | 1994-04-29 |
DK83889D0 (da) | 1989-02-23 |
AU613154B2 (en) | 1991-07-25 |
ATE94070T1 (de) | 1993-09-15 |
DK83889A (da) | 1989-08-25 |
IE890580L (en) | 1989-08-24 |
AU3024389A (en) | 1989-08-24 |
DE68908913T2 (de) | 1994-01-27 |
US5114916A (en) | 1992-05-19 |
IE63656B1 (en) | 1995-05-31 |
EP0330049B1 (en) | 1993-09-08 |
KR890012659A (ko) | 1989-09-18 |
EP0330049A2 (en) | 1989-08-30 |
EP0330049A3 (en) | 1991-01-30 |
PT89802A (pt) | 1989-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE77557T1 (de) | Zusammensetzung zur erhoehung der intrazell-atpspiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung. | |
ATE163849T1 (de) | Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure | |
DK642587D0 (da) | Insulinpraeparat | |
NO870241L (no) | Hypoglykemiske tiazolidindioner. | |
ES2059588T3 (es) | Factor xiii para la prevencion de una hemorragia intraventricular. | |
KR890011606A (ko) | 항응고제 | |
ATE71291T1 (de) | Pharmazeutische zubereitung mit verzoegerter freigabe. | |
ATA91797A (de) | Eine das vwf-propeptid enthaltende pharmazeutische präparation | |
ES2073425T3 (es) | Una nueva glicoproteina de tipo trombomodulina susceptible de ser obtenida a partir de la orina. | |
KR920017655A (ko) | 상처의 치료를 촉진시키기 위한 약학 조성물 | |
ES2032896T3 (es) | Procedimiento para la preparacion de cristales mixtos a base de insulina y derivados de insulina. | |
DE69133077D1 (de) | Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung | |
ATE5256T1 (de) | Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel. | |
DE69032000D1 (de) | Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten | |
ATE129895T1 (de) | Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten. | |
ATE126437T1 (de) | Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf. | |
ES2077698T3 (es) | Agente terapeutico para la gangrena diabetica. | |
KR910015294A (ko) | 약제 조성물 | |
AU5581186A (en) | Protein absorption enhancing agent | |
NO890261D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater. | |
DK417889A (da) | Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme | |
IT8721098A0 (it) | Derivati della 1-benzene solfonil 2-oco 5-alchiltio pirrolidina, un loro procedimentodi preparazione e il loro impiegocome stostanze medicinali. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 330049 Country of ref document: ES |